Clinical Research Trials
The only FDA approved medications available to patients with Alzheimer's disease are a class of medications that treat the cognitive symptoms of the disease. In 2021, the FDA approved the first ever medication aimed at removing amyloid pathology associated with Alzheimer's disease. There are several clinical research protocols available now of newer anti-amyloid and anti-tau treatments aimed at removing pathology and slowing progression of the symptoms of the disease. These trials are primarily available to individuals with Mild Cognitive Impairment due to Alzheimer's disease, and Alzheimer's disease in the mild stage.
There are no FDA approved treatments for the behavioral and psychiatric symptoms of Alzheimer's disease. However, there are clinical research protocols for newer medications aimed at reducing these symptoms.
If patients are eligible and interested, we will provide information about clinical trials. Most clinical trials are available to patients with Mild Cognitive Impairment and Alzheimer's disease in mild to moderate stages.
Contact us at 617-699-6927 to speak with one of our clinicians if you are interested in learning more about clinical trials.